India Panel Wants Johnson & Johnson To Pay Compensation Over Faulty Implants
The government made public an expert panel's report on alleged faulty hip replacement systems by a multinational company in India followings demands of the affected patients to release the report.
The Central Drugs Standard Control Organization under the Health Ministry put up the report on its website yesterday, which said pharma giant Johnson & Johnson “suppressed” facts on the harm caused by surgeries which were conducted on patients in India using “faulty” hip replacement systems.
A group of patients, who suffered due to alleged faulty hip replacement surgeries by a multinational firm, have written to Union Health Minister JP Nadda, saying it is surprising that the media has been able to get the report while the persons directly affected have been kept in the dark.
“Indeed, we are unable to make sense of these claims and media reports being unaware of the contents of the expert committee report, which is still secret,” they had said.
The report suggested that the company pay a compensation of around Rs 20 lakh to the affected patients.
The high-powered committee to examine issues related to faulty ASR hip implants manufactured by DePuy International Ltd. - a subsidiary of Johnson & Johnson - was constituted by the Health ministry under the chairmanship of AK Aggarwal, former dean of the Maulana Azad Medical College.
The committee, in its report, said that it found to be evasive in providing the information desired by the committee regarding the design of ASR, patient details, compensation details, adverse drug reaction reports etc.
“The firm also appears to be delayed in passing information and awareness about the failure of ASR,” it said.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
